Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Dementias study identifies funding gaps, opportunities for accelerating drug discovery and development NEW YORK, Sept.

PARIS and NEW YORK, JULY 6 /PRNewswire/ -- "People are actually more afraid of frailty than they are of dying," says Dr.

The risk of developing Alzheimer's Disease and Related Disorders (ADRD) may be reduced by about 40 percent in patients previously treated with intravenous immunoglobulin (IVIG) according to a study presented today at the 10th International Hong Kong/Springfield Pan-Asian Symposium on Advances in Alzheimer Therapy.

The Alzheimer's Drug Discovery Foundation (ADDF),

By ED SUSMAN The dreaded illness Alzheimer's disease -- the sickness that gradually robs people of their minds and bodies -- remains incurable -- but, doctors hope, not unbeatable.